Nongenomic vasodilator action of progesterone on primate coronary arteries

Richard D. Minshall, Dusan Pavcnik, David L. Browne, Kent Hermsmeyer

Research output: Contribution to journalArticle

56 Citations (Scopus)

Abstract

In the present investigation, we test the hypothesis that progesterone can rapidly relax, via a nongenomic mechanism, persistent flow occluding, agonist-activated coronary artery (CA) vasospasm, and hyperreactive vascular muscle cell (VMC) Ca 2+ responses in ovariectomized rhesus monkeys. CA vasospasm, induced by injection of 100 μM serotonin and 1 μM U-46619 (5-HT+U; 1 ml/30 s), resulted in a decrease in CA diameter (φ) from 1.8 ± 0.2 to 0.3 ± 0.1 mm at the site of focal constriction. Injection of 100 ng progesterone into the CA significantly relieved the severe vasoconstriction (1.3 ± 0.2 mm) and reestablished distal flow in 3 min; the preconstriction φ was completely restored in 8.2 ± 2.6 min (n = 6). Similarly, cell impermeant albumin-conjugated progesterone, but not albumin-conjugated 17β-estradiol, decreased 5-HT+U stimulated VMC Ca 2+ responses (250 ± 34% of basal 30 min after stimulation) back to the prestimulation level (113 ± 17% of basal) in 25 min (half time = 7 min). The presence of a rapid vasodilator action of progesterone in the primate CA and isolated VMC suggests its benefits in hormone replacement therapy may also include nongenomic vascular relaxant actions.

Original languageEnglish (US)
Pages (from-to)701-708
Number of pages8
JournalJournal of Applied Physiology
Volume92
Issue number2
StatePublished - 2002

Fingerprint

Vasodilator Agents
Primates
Progesterone
Blood Vessels
Coronary Vessels
Coronary Vasospasm
Muscle Cells
Serotonin
Albumins
15-Hydroxy-11 alpha,9 alpha-(epoxymethano)prosta-5,13-dienoic Acid
Injections
Hormone Replacement Therapy
Vasoconstriction
Macaca mulatta
Constriction
Estradiol

Keywords

  • Angiography
  • Low-dose progesterone
  • Nongenomic effects
  • Ovarian steroids
  • Vascular muscle cell
  • Vasospasm

ASJC Scopus subject areas

  • Physiology
  • Endocrinology
  • Orthopedics and Sports Medicine
  • Physical Therapy, Sports Therapy and Rehabilitation

Cite this

Minshall, R. D., Pavcnik, D., Browne, D. L., & Hermsmeyer, K. (2002). Nongenomic vasodilator action of progesterone on primate coronary arteries. Journal of Applied Physiology, 92(2), 701-708.

Nongenomic vasodilator action of progesterone on primate coronary arteries. / Minshall, Richard D.; Pavcnik, Dusan; Browne, David L.; Hermsmeyer, Kent.

In: Journal of Applied Physiology, Vol. 92, No. 2, 2002, p. 701-708.

Research output: Contribution to journalArticle

Minshall, RD, Pavcnik, D, Browne, DL & Hermsmeyer, K 2002, 'Nongenomic vasodilator action of progesterone on primate coronary arteries', Journal of Applied Physiology, vol. 92, no. 2, pp. 701-708.
Minshall RD, Pavcnik D, Browne DL, Hermsmeyer K. Nongenomic vasodilator action of progesterone on primate coronary arteries. Journal of Applied Physiology. 2002;92(2):701-708.
Minshall, Richard D. ; Pavcnik, Dusan ; Browne, David L. ; Hermsmeyer, Kent. / Nongenomic vasodilator action of progesterone on primate coronary arteries. In: Journal of Applied Physiology. 2002 ; Vol. 92, No. 2. pp. 701-708.
@article{42eb301a9570469ab2e55c57cb653fc5,
title = "Nongenomic vasodilator action of progesterone on primate coronary arteries",
abstract = "In the present investigation, we test the hypothesis that progesterone can rapidly relax, via a nongenomic mechanism, persistent flow occluding, agonist-activated coronary artery (CA) vasospasm, and hyperreactive vascular muscle cell (VMC) Ca 2+ responses in ovariectomized rhesus monkeys. CA vasospasm, induced by injection of 100 μM serotonin and 1 μM U-46619 (5-HT+U; 1 ml/30 s), resulted in a decrease in CA diameter (φ) from 1.8 ± 0.2 to 0.3 ± 0.1 mm at the site of focal constriction. Injection of 100 ng progesterone into the CA significantly relieved the severe vasoconstriction (1.3 ± 0.2 mm) and reestablished distal flow in 3 min; the preconstriction φ was completely restored in 8.2 ± 2.6 min (n = 6). Similarly, cell impermeant albumin-conjugated progesterone, but not albumin-conjugated 17β-estradiol, decreased 5-HT+U stimulated VMC Ca 2+ responses (250 ± 34{\%} of basal 30 min after stimulation) back to the prestimulation level (113 ± 17{\%} of basal) in 25 min (half time = 7 min). The presence of a rapid vasodilator action of progesterone in the primate CA and isolated VMC suggests its benefits in hormone replacement therapy may also include nongenomic vascular relaxant actions.",
keywords = "Angiography, Low-dose progesterone, Nongenomic effects, Ovarian steroids, Vascular muscle cell, Vasospasm",
author = "Minshall, {Richard D.} and Dusan Pavcnik and Browne, {David L.} and Kent Hermsmeyer",
year = "2002",
language = "English (US)",
volume = "92",
pages = "701--708",
journal = "Journal of Applied Physiology",
issn = "8750-7587",
publisher = "American Physiological Society",
number = "2",

}

TY - JOUR

T1 - Nongenomic vasodilator action of progesterone on primate coronary arteries

AU - Minshall, Richard D.

AU - Pavcnik, Dusan

AU - Browne, David L.

AU - Hermsmeyer, Kent

PY - 2002

Y1 - 2002

N2 - In the present investigation, we test the hypothesis that progesterone can rapidly relax, via a nongenomic mechanism, persistent flow occluding, agonist-activated coronary artery (CA) vasospasm, and hyperreactive vascular muscle cell (VMC) Ca 2+ responses in ovariectomized rhesus monkeys. CA vasospasm, induced by injection of 100 μM serotonin and 1 μM U-46619 (5-HT+U; 1 ml/30 s), resulted in a decrease in CA diameter (φ) from 1.8 ± 0.2 to 0.3 ± 0.1 mm at the site of focal constriction. Injection of 100 ng progesterone into the CA significantly relieved the severe vasoconstriction (1.3 ± 0.2 mm) and reestablished distal flow in 3 min; the preconstriction φ was completely restored in 8.2 ± 2.6 min (n = 6). Similarly, cell impermeant albumin-conjugated progesterone, but not albumin-conjugated 17β-estradiol, decreased 5-HT+U stimulated VMC Ca 2+ responses (250 ± 34% of basal 30 min after stimulation) back to the prestimulation level (113 ± 17% of basal) in 25 min (half time = 7 min). The presence of a rapid vasodilator action of progesterone in the primate CA and isolated VMC suggests its benefits in hormone replacement therapy may also include nongenomic vascular relaxant actions.

AB - In the present investigation, we test the hypothesis that progesterone can rapidly relax, via a nongenomic mechanism, persistent flow occluding, agonist-activated coronary artery (CA) vasospasm, and hyperreactive vascular muscle cell (VMC) Ca 2+ responses in ovariectomized rhesus monkeys. CA vasospasm, induced by injection of 100 μM serotonin and 1 μM U-46619 (5-HT+U; 1 ml/30 s), resulted in a decrease in CA diameter (φ) from 1.8 ± 0.2 to 0.3 ± 0.1 mm at the site of focal constriction. Injection of 100 ng progesterone into the CA significantly relieved the severe vasoconstriction (1.3 ± 0.2 mm) and reestablished distal flow in 3 min; the preconstriction φ was completely restored in 8.2 ± 2.6 min (n = 6). Similarly, cell impermeant albumin-conjugated progesterone, but not albumin-conjugated 17β-estradiol, decreased 5-HT+U stimulated VMC Ca 2+ responses (250 ± 34% of basal 30 min after stimulation) back to the prestimulation level (113 ± 17% of basal) in 25 min (half time = 7 min). The presence of a rapid vasodilator action of progesterone in the primate CA and isolated VMC suggests its benefits in hormone replacement therapy may also include nongenomic vascular relaxant actions.

KW - Angiography

KW - Low-dose progesterone

KW - Nongenomic effects

KW - Ovarian steroids

KW - Vascular muscle cell

KW - Vasospasm

UR - http://www.scopus.com/inward/record.url?scp=0036092594&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0036092594&partnerID=8YFLogxK

M3 - Article

VL - 92

SP - 701

EP - 708

JO - Journal of Applied Physiology

JF - Journal of Applied Physiology

SN - 8750-7587

IS - 2

ER -